What’s Next for Alzheimer’s Patients?: Perspectives on the Therapeutic Market and Patient Challenges

Custom content for InCrowd by Biopharma Dive's Brand Studio

ON-DEMAND WEBINAR
Duration: 1 hour

With 10% of those over the age of 65 in the U.S. affected, the impact of Alzheimer’s disease is as profound as its cure is elusive. In a search for answers, the InCrowd team asked prescribers, nurses and caregivers their perceptions on available treatments, challenges and coping strategies.

Join us as we review the insights from this research in our latest webinar. We'll address:

Historical context for the therapeutic path of Alzheimer’s disease and memory impairment
An overview of the patient population for Alzheimer’s disease
Prescriber perspectives on Alzheimer’s disease treatments and expectations
Insights from nurses and caregivers on daily challenges and the human toll of the condition

SPEAKERS

Diane Hayes, PhD
President and Co-Founder
InCrowd

Molly Simpson
Director of Client Engagement,
InCrowd

First Name *

Last Name *

Email *

Company *

Job Title *

Company Revenue *

Dive Publication